BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26774946)

  • 21. Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities.
    Morean ME; Davis DR; Kong G; Bold KW; Camenga DR; Suttiratana S; Lee J; Rajeshkumar L; Krishnan-Sarin S
    Drug Alcohol Depend; 2021 Nov; 228():109104. PubMed ID: 34607191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and correlates of "Vaping" as a route of cannabis administration in medical cannabis patients.
    Cranford JA; Bohnert KM; Perron BE; Bourque C; Ilgen M
    Drug Alcohol Depend; 2016 Dec; 169():41-47. PubMed ID: 27770657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical cannabis use in Canada: vapourization and modes of delivery.
    Shiplo S; Asbridge M; Leatherdale ST; Hammond D
    Harm Reduct J; 2016 Oct; 13(1):30. PubMed ID: 27793174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experiences of marijuana-vaporizer users.
    Malouff JM; Rooke SE; Copeland J
    Subst Abus; 2014; 35(2):127-8. PubMed ID: 24821347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA.
    Kowitt SD; Osman A; Meernik C; Zarkin GA; Ranney LM; Martin J; Heck C; Goldstein AO
    BMJ Open; 2019 Jun; 9(6):e028535. PubMed ID: 31196904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017-19.
    Keyes KM; Kreski NT; Ankrum H; Cerdá M; Chen Q; Hasin DS; Martins SS; Olfson M; Miech R
    Addiction; 2022 Aug; 117(8):2316-2324. PubMed ID: 35588004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing marijuana concentrate users: A web-based survey.
    Daniulaityte R; Lamy FR; Barratt M; Nahhas RW; Martins SS; Boyer EW; Sheth A; Carlson RG
    Drug Alcohol Depend; 2017 Sep; 178():399-407. PubMed ID: 28704769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the research community respond adequately to the health risks of vaping?
    Cox B
    Addiction; 2015 Nov; 110(11):1708-9. PubMed ID: 26471153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vape Factor Fast Find-Adult (VF3-A): a prototype survey method for recording brand-specific vaping factors in adult populations.
    Ross CS; Zhang TC; DeJong W; Siegel M
    Tob Control; 2019 Jan; 28(1):20-26. PubMed ID: 29572355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are vaporizers a lower-risk alternative to smoking cannabis?
    Chaiton M; Kundu A; Rueda S; Di Ciano P
    Can J Public Health; 2022 Apr; 113(2):293-296. PubMed ID: 34448130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between Dual Users and Switchers Center around Vaping Behavior and Its Experiences Rather than Beliefs and Attitudes.
    Adriaens K; Van Gucht D; Baeyens F
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases in Frequent Vaping of Cannabis Among High School Seniors in the United States, 2018-2019.
    Palamar JJ
    J Adolesc Health; 2021 Jul; 69(1):153-156. PubMed ID: 33972170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaping cannabis (marijuana): parallel concerns to e-cigs?
    Budney AJ; Sargent JD; Lee DC
    Addiction; 2015 Nov; 110(11):1699-704. PubMed ID: 26264448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel trajectories of vaping and smoking cannabis and their associations with mental and physical well-being among young adults.
    Dunbar MS; Davis JP; Tucker JS; Seelam R; Rodriguez A; D'Amico EJ
    Drug Alcohol Depend; 2023 Oct; 251():110918. PubMed ID: 37611482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington.
    Davis KC; Allen J; Duke J; Nonnemaker J; Bradfield B; Farrelly MC; Shafer P; Novak S
    PLoS One; 2016; 11(1):e0146853. PubMed ID: 26800209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaping preferences of individuals who vaporise dry herb cannabis, cannabis liquids and cannabis concentrates.
    Morgan J; Gschwend G; Houston M; Jones A; Kelso C
    Drug Alcohol Depend; 2022 Nov; 240():109632. PubMed ID: 36152405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Short Form Vaping Consequences Questionnaire: Psychometric Properties of a Measure of Vaping Expectancies for Use With Adult E-cigarette Users.
    Morean ME; L'Insalata A
    Nicotine Tob Res; 2017 Feb; 19(2):215-221. PubMed ID: 27613904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of flavored cannabis vaping products in the US, Canada, Australia, and New Zealand: findings from the international cannabis policy study wave 4 (2021).
    D'Mello K; Chan GCK; Hall W; Rychert M; Wilkins C; Hammond D
    Am J Drug Alcohol Abuse; 2023 Sep; 49(5):640-651. PubMed ID: 37624645
    [No Abstract]   [Full Text] [Related]  

  • 39. Past 30-Day Marijuana Vaping: Prevalence and Predictors of Use in a Nationally Representative Study of U.S. Youth.
    Kritikos AF; Johnson JK; Hodgkin D
    Am J Prev Med; 2021 Feb; 60(2):258-266. PubMed ID: 33309447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern and prevalence of vaping nicotine and non-nicotine drugs in the United Kingdom: a cross-sectional study.
    Roberts E; Taylor E; Cox S; Brose L; McNeill A; Robson D
    BMJ Open; 2023 Apr; 13(4):e066826. PubMed ID: 37185643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.